Skip to Main Content

Paper Details

Real-World Experience Using Intravitreal Brolucizumab Alone or in Combination with Aflibercept in the Management of Neovascular Age-Related Macular Degeneration.
Clin Ophthalmol
2
2023
Aflibercept, Brolucizumab, IVBr, Neovascular Age-Related Macular Degeneration, VEGF, aflibercept, anti-VEGF, brolucizumab, intraocular inflammation, macular fluid, nAMD, neovascular age-related macular degeneration, patients, vision
Author NameAffiliation
Ala MoshiriUniversity of California Davis Health
Glenn YiuUniversity of California Davis Health
  • 1 - 2

Datasets

Release 1.2